Thermo Fisher Scientific Inc
NYSE:TMO

Watchlist Manager
Thermo Fisher Scientific Inc Logo
Thermo Fisher Scientific Inc
NYSE:TMO
Watchlist
Price: 579.94 USD 0.74% Market Closed
Market Cap: 217.9B USD

Intrinsic Value

The intrinsic value of one TMO stock under the Base Case scenario is 525.56 USD. Compared to the current market price of 579.94 USD, Thermo Fisher Scientific Inc is Overvalued by 9%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TMO Intrinsic Value
525.56 USD
Overvaluation 9%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Thermo Fisher Scientific Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about TMO?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is TMO valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Thermo Fisher Scientific Inc.

Explain Valuation
Compare TMO to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Thermo Fisher’s significant reliance on government-funded research budgets makes it vulnerable to potential cuts in public R&D spending, which could slow its top-line growth and margin expansion in the event of policy shifts.

Recent large-scale acquisitions pose integration risks and potential margin dilution if Thermo Fisher cannot execute synergy targets and effectively align acquired businesses under its operational umbrella.

A decline in COVID-19 testing demand, which contributed heavily to revenue during the pandemic, could result in near-term comparability challenges, exposing lower organic growth rates across other business segments.

Bull Theses

Thermo Fisher’s extensive portfolio of scientific instruments, lab consumables, and diagnostic equipment creates a one-stop shop for research institutions, driving recurring revenue streams through cross-selling and high customer retention.

Its strategic acquisitions, such as Life Technologies, have enhanced Thermo Fisher’s capabilities in genetic testing and advanced diagnostics, positioning it to benefit from long-term trends in personalized medicine and biotech innovation.

Strong cash generation and a robust balance sheet allow the company to reinvest in R&D and pursue targeted acquisitions, fueling continuous product development and expansion into high-growth sectors like cell and gene therapy.

Show More Less
How do you feel about TMO?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Thermo Fisher Scientific Inc

Current Assets 22.3B
Cash & Short-Term Investments 3.5B
Receivables 8.9B
Other Current Assets 9.8B
Non-Current Assets 80.7B
PP&E 10.2B
Intangibles 65.5B
Other Non-Current Assets 5B
Current Liabilities 14.9B
Other Current Liabilities 14.9B
Non-Current Liabilities 37.1B
Long-Term Debt 31.9B
Other Non-Current Liabilities 5.3B
Efficiency

Free Cash Flow Analysis
Thermo Fisher Scientific Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Thermo Fisher Scientific Inc

Revenue
43.7B USD
Cost of Revenue
-25.6B USD
Gross Profit
18.1B USD
Operating Expenses
-10.1B USD
Operating Income
8B USD
Other Expenses
-1.5B USD
Net Income
6.6B USD
Fundamental Scores

TMO Profitability Score
Profitability Due Diligence

Thermo Fisher Scientific Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Healthy Operating Margin
Positive 3Y Average ROE
Sustainable 3Y Average Gross Margin
51/100
Profitability
Score

Thermo Fisher Scientific Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

TMO Solvency Score
Solvency Due Diligence

Thermo Fisher Scientific Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
45/100
Solvency
Score

Thermo Fisher Scientific Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TMO Price Targets Summary
Thermo Fisher Scientific Inc

Wall Street analysts forecast TMO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TMO is 646.25 USD with a low forecast of 538.49 USD and a high forecast of 787.5 USD.

Lowest
Price Target
538.49 USD
7% Downside
Average
Price Target
646.25 USD
11% Upside
Highest
Price Target
787.5 USD
36% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for TMO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

TMO Insider Trading
Buy and sell transactions by insiders

TMO News

Other Videos
What is the Intrinsic Value of one TMO stock?

The intrinsic value of one TMO stock under the Base Case scenario is 525.56 USD.

Is TMO stock undervalued or overvalued?

Compared to the current market price of 579.94 USD, Thermo Fisher Scientific Inc is Overvalued by 9%.

Back to Top